LumediX develops functionalized luminescent nanoparticles for bioanalytical and in vitro diagnostic applications. The nanoparticles they use enhance immunoassay sensitivity, allowing timely access to Healthcare, for everyone, everywhere. The company is based in Paris.
Medical Device, Nanotechnology, Nanoparticles, Biophotonics
No funding announced yet
💡 You’re a corporate or investor and looking for startups that are innovating in the same market as LumediX? We’re happy to assist you with our Startup Sourcing service.